Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg
Condition: Bioequivalence Intervention: Drug: Orlistat 60mg Cap Sponsor: Shandong New Time Pharmaceutical Co., LTD Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2021 Category: Research Source Type: clinical trials
Study of IFN- α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL)
Condition: B-cell Acute Lymphoblastic Leukemia Intervention: Combination Product: IFN-α combined with CAR-T cell therapy Sponsor: The First Affiliated Hospital of Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2020 Category: Research Source Type: clinical trials